03:51 PM EST - Valeant Pharmaceuticals International, Inc. : announced today that Valeant has agreed to acquire OraPharma, a specialty oral health company that develops and commercializes products that improve and maintain oral health, from Water Street Healthcare Partners, a private equity firm focused exclusively on the health care industry. Total consideration is approximately $312 million and up to $114 million in potential contingent payments based on certain milestones, including revenue targets. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading down $1.03 at $46.03.
